Date Title Description PDF
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download
03 Nov 2021 On buy-back programmes The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. Download
16 Jul 2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company   Download
22 Jun 2021 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. Download

Pages

Date Title Description PDF
03 Jul 2025 Other relevant information The Company informs about the dividends payment.  Download
18 Jun 2025 Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download
08 May 2025 On business and financial situation The Company releases the press release related to the first three months of 2025 financial results Download
08 May 2025 On business and financial situation The Company releases the first three months 2025 financial results presentation Download
08 May 2025 Announcement of General Shareholders’ Meeting The Company announces the call of its 2025 Ordinary General Shareholders' Meeting Download

Pages

Date Title Description PDF
30 Jul 2014 información sobre resultados Download
30 Jul 2014 información sobre resultados (2) Download
01 Jul 2014 Información sobre dividendos Download
12 Jun 2014 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
29 Apr 2014 Información sobre resultados (2) Download

Pages